Emgality and Narcan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Emgality (galcanezumab-gnlm) and Narcan (naloxone hydrochloride). Common drug interactions include allergy to chemicals among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Emgality and Narcan. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

What is Narcan?

Narcan has active ingredients of naloxone hydrochloride. eHealthMe is studying from 3,687 Narcan users. Check the latest studies of Narcan.



On Jul, 13, 2026

16 people who take Emgality and Narcan together, and have interactions are studied.

Emgality and Narcan drug interactions.

What are the common drug interactions of Emgality and Narcan, by gender? *:

female:

  1. Allergy to chemicals
  2. Dehydration (dryness resulting from the removal of water)
  3. Dizziness
  4. Flushing (the warm, red condition of human skin)
  5. Hypokalaemia (low potassium)
  6. Irritable bowel syndrome
  7. Memory impairment
  8. Migraine (headache)
  9. Nausea (feeling of having an urge to vomit)
  10. Pain in jaw

male:

  1. Back pain
  2. Cat scratch disease (bacterial infection by cat scratch)
  3. Increased appetite
  4. Memory impairment
  5. Muscle spasms (muscle contraction)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the common drug interactions of Emgality and Narcan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Back pain
  2. Cat scratch disease (bacterial infection by cat scratch)
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Constipation
  5. Cyclic vomiting syndrome (prolonged episodes of severe nausea, vomiting)
  6. Drug ineffective
  7. Dyskinesia (abnormality or impairment of voluntary movement)
  8. Hyposmia (impairment of the sense of smell)
  9. Impaired gastric emptying
  10. Increased appetite

30-39:

n/a

40-49:

  1. Allergy to chemicals
  2. Migraine (headache)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Pain in jaw
  6. Polymenorrhoea (menstrual disorder)
  7. Vomiting
  8. Arthralgia (joint pain)
  9. Chest discomfort
  10. Chills (felling of cold)

50-59:

  1. Death

60+:

n/a

What are the existing conditions these people have? *

  1. Drowsiness: 6 people, 37.50%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 31.25%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 31.25%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 18.75%
  5. Nausea (feeling of having an urge to vomit): 3 people, 18.75%
  6. Nausea And Vomiting: 2 people, 12.50%
  7. Parkinson's Disease: 1 person, 6.25%
  8. Migraine (headache): 1 person, 6.25%
  9. Hallucinations (sensations that appear real but are created by your mind): 1 person, 6.25%
  10. Depression: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Emgality and Narcan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Emgality and Narcan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Narcan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emgality and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Narcan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on galcanezumab-gnlm and naloxone hydrochloride (the active ingredients of Emgality and Narcan, respectively), and Emgality and Narcan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: